Lung Diseases

Researchers find new treatment to reverse COPD and other lung diseases

In a study conducted on mice, researchers found a receptor that could reverse inflammatory responses and combat chronic obstructive pulmonary disease (COPD) and other lung diseases.

Lung X-Ray
Lung X-Ray
Source: Shutterstock: sfam_photo

The findings, published in The FASEB Journal, found that the helpful receptor is one characterized for advanced glycan end-products (RAGE)-specific antagonist chemical compound, FPS-ZM1.

"RAGE disturbances in pulmonary disorders are precise and effective strategies with beneficial clinical effects," said Se-Ran Yang, PhD, an author on the study and an associate professor at the Department of Thoracic and Cardiovascular Surgery in the School of Medicine at Kangwon National University in Gangwon, Korea. "Blockade of RAGE as a novel clinical therapeutic for COPD ameliorates emphysema/COPD development and progression."

The researchers investigated the efficacy of the receptor in both vivo and in vitro COPD models to see what the molecular mechanism by which RAGE influences COPD.

They found that RAGE was association with the up-regulation of DAMP-related signaling pathways. FPS-ZM1 also reversed emphysematous lung symptoms in the mice by a significant margin.

"No one expected the pathogenic roots of COPD to be simple, and this study gives us an indication of the complexity involved.," said Thoru Pederson, PhD, editor-in-chief of  The FASEB Journal. "The current pharmacological armamentarium is limited, and studies like this are thus extremely valuable as a foundation."

Source: Radiology Business

21.02.2017

Read all latest stories

Related articles

Photo

Artificial Intelligence

New type of early warning system detects lung diseases

Chronic illnesses can have a dramatic impact on a patient's later life. An early diagnosis of such diseases opens up the possibility of taking medical action in good time.

Photo

Chronic obstructive pulmonary disease

COPD: Biomarker for kidney disease has unexpected benefits

A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American…

Photo

Therapy

New way to predict COPD progression

New research has found that a process initiated in white blood cells known as neutrophils may lead to worse outcomes for some patients with chronic obstructive pulmonary disease (COPD). The discovery…

Related products

Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Sarstedt – Low DNA Binding Micro Tubes

Research Use Only (RUO)

Sarstedt – Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG
Shimadzu – CLAM-2030

Research Use Only (RUO)

Shimadzu – CLAM-2030

Shimadzu Europa GmbH
Subscribe to Newsletter